Skip to main content
Top
Published in: Clinical Rheumatology 9/2007

01-09-2007 | Case Report

The expanded clinical spectrum of familial Mediterranean fever

Authors: Z. Birsin Özçakar, Fatoş Yalçınkaya, Selçuk Yüksel, Mesiha Ekim

Published in: Clinical Rheumatology | Issue 9/2007

Login to get access

Abstract

The classical clinical features of familial Mediterranean fever (FMF) are recurrent self-limited attacks of fever and serositis. Amyloidosis of the AA type is the major complication of the disease. The diagnosis of FMF is still based on a history of typical acute attacks, ethnic background, and frequently, notable family history. Together with the discovery of MEFV gene, the clinical criteria for the diagnosis of the disease did not change. Although we have learned a great deal about the clinical features and the pathogenesis of FMF in the past few years, many atypical cases emerge, and caution should be exercised during diagnosis. In this report, we present three FMF patients not fulfilling clinical criteria for the diagnosis, discuss rare and unusual presentations of the disease, and emphasize the role of genetic analysis in these suspicious cases.
Literature
1.
go back to reference Yalçınkaya F, Çakar N, Mısırlıoğlu M, Tümer N, Akar N, Tekin M (2000) Genotype–phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatol 39:67–72CrossRef Yalçınkaya F, Çakar N, Mısırlıoğlu M, Tümer N, Akar N, Tekin M (2000) Genotype–phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatol 39:67–72CrossRef
2.
go back to reference Siegal S (1945) Benign paroxysmal peritonitis. Ann Intern Med 23:1–21 Siegal S (1945) Benign paroxysmal peritonitis. Ann Intern Med 23:1–21
3.
go back to reference Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302PubMed Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302PubMed
4.
go back to reference Özkan E, Okur Ö, Ekmekçi A, Özcan R, Tağ T (1972) A new approach to the treatment of periodic fever. Med Bull İstanbul Univ 5:44–49 Özkan E, Okur Ö, Ekmekçi A, Özcan R, Tağ T (1972) A new approach to the treatment of periodic fever. Med Bull İstanbul Univ 5:44–49
5.
go back to reference Langevitz P, Zemer D, Livneh A, Shemer J, Pras M (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMed Langevitz P, Zemer D, Livneh A, Shemer J, Pras M (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMed
6.
go back to reference Eshel G, Zemer D, Bar-Yochai A (1987) Acute orchitis in familial Mediterranean fever. Ann Intern Med 109:164–165 Eshel G, Zemer D, Bar-Yochai A (1987) Acute orchitis in familial Mediterranean fever. Ann Intern Med 109:164–165
7.
go back to reference Yalçınkaya F, Tümer N (1999) Glomerular lesions other than amyloidosis in patients with FMF. Nephrol Dial Transplant 14:21–25PubMedCrossRef Yalçınkaya F, Tümer N (1999) Glomerular lesions other than amyloidosis in patients with FMF. Nephrol Dial Transplant 14:21–25PubMedCrossRef
8.
go back to reference Langevitz P, Livneh A, Zemer D, Shemer J, Pras M (1997) Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 27:67–72PubMedCrossRef Langevitz P, Livneh A, Zemer D, Shemer J, Pras M (1997) Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 27:67–72PubMedCrossRef
9.
go back to reference Tutar E, Yalçınkaya F, Özkaya N, Ekim M, Atalay S (2003) Incidence of pericardial effusion during attacks of familial Mediterranean fever. Heart 89:1257–1258PubMedCrossRef Tutar E, Yalçınkaya F, Özkaya N, Ekim M, Atalay S (2003) Incidence of pericardial effusion during attacks of familial Mediterranean fever. Heart 89:1257–1258PubMedCrossRef
10.
go back to reference Tekin M, Yalçınkaya F, Tümer N, Akar N, Mısırlıoğlu M, Çakar N (2000) Clinical, laboratory and molecular characteristics of children with familial Mediterranean fever-associated vasculitis. Acta Paediatr 89:177–182PubMedCrossRef Tekin M, Yalçınkaya F, Tümer N, Akar N, Mısırlıoğlu M, Çakar N (2000) Clinical, laboratory and molecular characteristics of children with familial Mediterranean fever-associated vasculitis. Acta Paediatr 89:177–182PubMedCrossRef
11.
go back to reference Tunca M, Akar S, Önen F et al, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef Tunca M, Akar S, Önen F et al, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef
12.
go back to reference The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807CrossRef The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807CrossRef
13.
go back to reference Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef
14.
go back to reference Kastner DL (1998) Familial Mediterranean fever: the genetics of inflammation. Hosp Pract 33:131–148CrossRef Kastner DL (1998) Familial Mediterranean fever: the genetics of inflammation. Hosp Pract 33:131–148CrossRef
15.
go back to reference Zemer D, Livneh A, Danon YL, Pras M, Sohar E (1991) Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34:973–977PubMedCrossRef Zemer D, Livneh A, Danon YL, Pras M, Sohar E (1991) Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34:973–977PubMedCrossRef
Metadata
Title
The expanded clinical spectrum of familial Mediterranean fever
Authors
Z. Birsin Özçakar
Fatoş Yalçınkaya
Selçuk Yüksel
Mesiha Ekim
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0447-3

Other articles of this Issue 9/2007

Clinical Rheumatology 9/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.